Just 20 seconds of exercise? study tests Ultra-Short sprints for fitness
NCT ID NCT07328568
First seen Jun 25, 2026 · Last updated Aug 25, 2026 · Updated 3 times
Summary
This study tests whether doing very short, intense bike sprints—just 10 to 20 seconds, twice a week—can improve cardiorespiratory fitness in inactive adults. Sixty healthy, overweight but otherwise healthy participants will complete 18 sessions over 9 weeks, and their results will be compared to a group that does not exercise. The goal is to see if such a tiny amount of exercise can meaningfully boost fitness and health, which could eventually help update public health guidelines.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- reduced exertion high intensity interval training (REHIT) on a stationary bike
- What this could lead to
- If it works, this could show that just a few seconds of intense exercise per week can meaningfully improve fitness, potentially leading to simpler exercise recommendations for inactive adults.
- What could go wrong
- This is a small, early-stage study with only 60 participants. The exercise dose is very low, so the fitness improvements may be small or not clinically meaningful. Results may not apply to older or less healthy adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy * BMI \< 35 kg/m2 * younger than 56 yr old * no joint issues Exclusion Criteria: * Those adults who are currently active and not weight stable * Adults with BMI \> 35 kg/m2 * Use of medications which may alter study outcomes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
California State University--San Marcos Human Performance Laboratory
RECRUITINGSan Marcos, California, 92096, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body